Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Cantor Fitzgerald
AstraZeneca
Farmers Insurance
Johnson and Johnson
Julphar
Queensland Health
Moodys
Cipla
Argus Health

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 079244

« Back to Dashboard

NDA 079244 describes LORAZEPAM, which is a drug marketed by Amneal Pharms, Hi-tech Pharma Co, Lupin Ltd, Pharm Assoc, Saptalis Pharms, Akorn, Bedford, Dava Pharms Inc, Hospira, Intl Medication Sys, Sagent Agila Llc, Watson Labs, Watson Labs Inc, West-ward Pharms Int, Roxane, Am Therap, Anda Repository, Ani Pharms Inc, Halsey, Leading Pharma Llc, Mutual Pharm, Mylan, Par Pharm, Sandoz, Sun Pharm Inds Ltd, Superpharm, Usl Pharma, Vintage Pharms, Warner Chilcott, and Bedford Labs, and is included in sixty-seven NDAs. It is available from fifty-two suppliers. Additional details are available on the LORAZEPAM profile page.

The generic ingredient in LORAZEPAM is lorazepam. There are eleven drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the lorazepam profile page.
Summary for 079244
Tradename:LORAZEPAM
Applicant:Saptalis Pharms
Ingredient:lorazepam
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 079244

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CONCENTRATE;ORALStrength2MG/ML
Approval Date:Apr 28, 2009TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Harvard Business School
Boehringer Ingelheim
Daiichi Sankyo
Chinese Patent Office
McKinsey
Healthtrust
US Department of Justice
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot